Cognition Therapeutics Inc (NAS:CGTX)
$ 2.62 0.35 (15.42%) Market Cap: 104.95 Mil Enterprise Value: 57.30 Mil PE Ratio: 0 PB Ratio: 3.14 GF Score: 21/100

Q4 2022 Cognition Therapeutics Inc Earnings Call Transcript

Mar 23, 2023 / 12:00PM GMT
Release Date Price: $1.83 (-1.61%)
Operator

Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics, Inc. Fourth Quarter and Fiscal Year 2022 Earnings Conference Call. My name is Julianne, and I will be your conference operator today. This call is being recorded. I would like to turn the presentation over now to your host for today's call, Daniel Kontoh-Boateng, Investor Relations for Cognition Therapeutics. Please go ahead, Mr. Kontoh-Boateng.

Unidentified Company Representative

Thank you, Julianne. Good morning, and thank you for participating in Cognition Therapeutics conference call today. With me today are Lisa Ricciardi, President and Chief Executive Officer of Cognition; and Andrew Einhorn, Interim Chief Financial Officer of Cognition. A press release detailing Cognition Therapeutics 2022 results is available on the Investors section of our website at cogrx.com. We encourage everyone to read this morning's press release as well as Cognition's annual report on Form 10-K, which is now filed with the SEC and available on our website.

In addition, this conference call is being

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot